# Moleculin Biotech, Inc. — Form D

Moleculin Biotech, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-16. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-05-16
- Form: D
- Accession: 0001659617-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 129
- Date of first sale: 2016-05-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-263286

## Issuer

- Name: Moleculin Biotech, Inc.
- CIK: 0001659617
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2575 WEST BELLFORT, HOUSTON, TX, 77054
- Phone: 713-300-5160

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Walter Klemp | Director | The Woodlands, TX |
| Walter Klemp | Executive Officer | The Woodlands, TX |
| Louis Ploth | Executive Officer | Houston, TX |

## More

- [CIK 1659617 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1659617&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001659617-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.